Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis
Slobodan M JankovicPharmacology Department, Medical Faculty, University of Kragujevac, Kragujevac, SerbiaAbstract: Multiple sclerosis (MS) is chronic inflammatory and demyelinating disease with either a progressive (10%–15%) or relapsing-remitting (85%–90%) course. The pa...
Enregistré dans:
Auteur principal: | Slobodan M Jankovic |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2010
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5b85b4be0c234d4daefdbd2f0a9208a1 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Expression analysis of protein inhibitor of activated STAT (PIAS) genes in IFNβ-treated multiple sclerosis patients [Corrigendum]
par: Taheri M, et autres
Publié: (2019) -
Alemtuzumab in the treatment of multiple sclerosis
par: Fernandez Ó
Publié: (2014) -
Emerging therapies for treatment of multiple sclerosis
par: John R Corboy, et autres
Publié: (2010) -
The effect of smoking on the symptoms and progression of multiple sclerosis: a review
par: Afsaneh Shirani, et autres
Publié: (2010) -
Vascular involvement in systemic sclerosis (scleroderma)
par: Pattanaik D, et autres
Publié: (2011)